Header and Body 2

Problem Addressed

In the United States, children commonly receive at least 10 recommended immunizations, most of which also require two to four booster dosages. The requirement for boosters both increases healthcare costs and decreases patient compliance due to the need for repeated return visits. Technologies that enhance the immune response from a single dosage could help to solve the issues associated multi-dose immunizations. These inventors have engineered a peptide that enhances immune responses in vaccines by conjugating protein antigens directly to alum adjuvants.